Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilon Health, Inc. stock logo
AGL
Agilon Health
$53.86
-11.2%
$18.83
$7.48
$82.00
$1.01B2.29561,295 shs859,452 shs
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$15.96
+5.6%
$15.82
$13.46
$31.04
$449.48M0.88558,531 shs754,530 shs
Charming Medical Ltd stock logo
MCTA
Charming Medical
$29.36
+6.8%
$29.36
$4.30
$31.70
$497.21MN/AN/A4.25 million shs
KindlyMD, Inc. stock logo
NAKA
KindlyMD
$0.18
-1.6%
$0.23
$0.17
$34.77
$124.20M17.126.53 million shs5.54 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilon Health, Inc. stock logo
AGL
Agilon Health
0.00%+115.61%+225.71%+271.89%-28.90%
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
0.00%-0.53%-4.55%-35.54%-19.12%
Charming Medical Ltd stock logo
MCTA
Charming Medical
0.00%0.00%0.00%+0.02%+2,935,999,900.00%
KindlyMD, Inc. stock logo
NAKA
KindlyMD
0.00%+2.21%-14.49%-38.75%+17,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilon Health, Inc. stock logo
AGL
Agilon Health
$53.86
-11.2%
$18.83
$7.48
$82.00
$1.01B2.29561,295 shs859,452 shs
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$15.96
+5.6%
$15.82
$13.46
$31.04
$449.48M0.88558,531 shs754,530 shs
Charming Medical Ltd stock logo
MCTA
Charming Medical
$29.36
+6.8%
$29.36
$4.30
$31.70
$497.21MN/AN/A4.25 million shs
KindlyMD, Inc. stock logo
NAKA
KindlyMD
$0.18
-1.6%
$0.23
$0.17
$34.77
$124.20M17.126.53 million shs5.54 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilon Health, Inc. stock logo
AGL
Agilon Health
0.00%+115.61%+225.71%+271.89%-28.90%
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
0.00%-0.53%-4.55%-35.54%-19.12%
Charming Medical Ltd stock logo
MCTA
Charming Medical
0.00%0.00%0.00%+0.02%+2,935,999,900.00%
KindlyMD, Inc. stock logo
NAKA
KindlyMD
0.00%+2.21%-14.49%-38.75%+17,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilon Health, Inc. stock logo
AGL
Agilon Health
2.14
Hold$37.93-29.58% Downside
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
2.20
Hold$27.0069.17% Upside
Charming Medical Ltd stock logo
MCTA
Charming Medical
1.00
SellN/AN/A
KindlyMD, Inc. stock logo
NAKA
KindlyMD
2.40
Hold$0.75323.49% Upside

Current Analyst Ratings Breakdown

Latest NAKA, MCTA, AGL, and FLGT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2026
Agilon Health, Inc. stock logo
AGL
Agilon Health
Reiterated RatingOverweight$37.50 ➝ $72.00
5/7/2026
Agilon Health, Inc. stock logo
AGL
Agilon Health
UpgradeHoldBuy$27.50 ➝ $48.00
5/7/2026
Agilon Health, Inc. stock logo
AGL
Agilon Health
UpgradeHoldBuy$33.00 ➝ $49.00
5/7/2026
Agilon Health, Inc. stock logo
AGL
Agilon Health
Boost Price TargetNeutral$20.00 ➝ $35.00
5/5/2026
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
Reiterated RatingNeutral$30.00 ➝ $15.00
5/4/2026
Agilon Health, Inc. stock logo
AGL
Agilon Health
DowngradeNeutralUnderweight$21.00
4/20/2026
Agilon Health, Inc. stock logo
AGL
Agilon Health
Reiterated RatingSell (E+)
4/10/2026
KindlyMD, Inc. stock logo
NAKA
KindlyMD
Initiated CoverageBuy$1.00
4/9/2026
Agilon Health, Inc. stock logo
AGL
Agilon Health
Set Price TargetHold$33.00
4/6/2026
KindlyMD, Inc. stock logo
NAKA
KindlyMD
Lower Price TargetBuy$1.50 ➝ $0.75
4/2/2026
Agilon Health, Inc. stock logo
AGL
Agilon Health
Boost Price TargetBuy$13.00
(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilon Health, Inc. stock logo
AGL
Agilon Health
$5.82B0.15N/AN/A$10.88 per share4.95
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$322.67M1.47N/AN/A$35.10 per share0.45
Charming Medical Ltd stock logo
MCTA
Charming Medical
N/AN/AN/AN/AN/AN/A
KindlyMD, Inc. stock logo
NAKA
KindlyMD
$1.82M67.14N/AN/A$1.17 per share0.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilon Health, Inc. stock logo
AGL
Agilon Health
-$391.35M-$21.56N/AN/AN/A-6.09%-146.03%-24.55%N/A
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
-$60.51M-$2.39N/AN/AN/A-23.04%-3.24%-2.97%N/A
Charming Medical Ltd stock logo
MCTA
Charming Medical
N/AN/AN/AN/AN/AN/AN/AN/AN/A
KindlyMD, Inc. stock logo
NAKA
KindlyMD
-$52.23M-$0.87N/A5.90N/A-2,866.57%-16.11%-11.25%N/A

Latest NAKA, MCTA, AGL, and FLGT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2026Q1 2026
Agilon Health, Inc. stock logo
AGL
Agilon Health
$1.04$1.80+$0.76$2.94$1.38 billion$1.42 billion
2/27/2026Q4 2025
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$0.02$0.16+$0.14-$0.76$85.38 million$83.34 million
2/25/2026Q4 2025
Agilon Health, Inc. stock logo
AGL
Agilon Health
-$0.27-$0.46-$0.19-$11.50$1.46 billion$1.57 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agilon Health, Inc. stock logo
AGL
Agilon Health
$1.803.34%N/AN/A N/A
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
N/AN/AN/AN/AN/A
Charming Medical Ltd stock logo
MCTA
Charming Medical
N/AN/AN/AN/AN/A
KindlyMD, Inc. stock logo
NAKA
KindlyMD
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilon Health, Inc. stock logo
AGL
Agilon Health
0.08
1.04
1.02
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
N/A
5.31
6.48
Charming Medical Ltd stock logo
MCTA
Charming Medical
N/AN/AN/A
KindlyMD, Inc. stock logo
NAKA
KindlyMD
N/A
1.04
1.04

Institutional Ownership

CompanyInstitutional Ownership
Agilon Health, Inc. stock logo
AGL
Agilon Health
N/A
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
48.06%
Charming Medical Ltd stock logo
MCTA
Charming Medical
N/A
KindlyMD, Inc. stock logo
NAKA
KindlyMD
N/A

Insider Ownership

CompanyInsider Ownership
Agilon Health, Inc. stock logo
AGL
Agilon Health
2.30%
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
36.18%
Charming Medical Ltd stock logo
MCTA
Charming Medical
N/A
KindlyMD, Inc. stock logo
NAKA
KindlyMD
24.49%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilon Health, Inc. stock logo
AGL
Agilon Health
1,07616.66 million16.28 millionNot Optionable
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
1,31529.75 million18.99 millionOptionable
Charming Medical Ltd stock logo
MCTA
Charming Medical
4916.94 millionN/AN/A
KindlyMD, Inc. stock logo
NAKA
KindlyMD
N/A690.02 million521.03 millionN/A

Recent News About These Companies

TD Cowen Begins Coverage on KindlyMD (NASDAQ:NAKA)
Kindly MD Faces Nasdaq Non-Compliance Notice
Kindly MD Appoints New CFO and CAO
BTC Inc Appoints Brandon Green as Chief Executive Officer
Kindly MD Delays 10-Q Filing Amid Merger Complexity

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilon Health stock logo

Agilon Health NYSE:AGL

$53.86 -6.81 (-11.22%)
Closing price 05/8/2026 03:58 PM Eastern
Extended Trading
$55.12 +1.26 (+2.34%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Fulgent Genetics stock logo

Fulgent Genetics NASDAQ:FLGT

$15.96 +0.85 (+5.63%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$15.82 -0.14 (-0.88%)
As of 05/8/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

Charming Medical stock logo

Charming Medical NASDAQ:MCTA

$29.36 +1.86 (+6.76%)
As of 05/8/2026 03:30 PM Eastern

We are a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. We offer a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance. Operating under the Beauty Lab Group (“Beauty Lab”) brand, our Operating Subsidiaries in Hong Kong offer a wide range of TCM-inspired beauty, wellness, and postpartum therapies and products through our four wellness centers in Hong Kong. Our services are designed to meet diverse health improvement needs, including alleviating premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal care, breast health, and other common women’s health conditions. We believe that our TCM-inspired herbal therapies can help balance the female endocrine system and improve women’s constitution and overall health. Additionally, the Operating Subsidiaries offer TCM-inspired therapies tailored to men. We offer a wide range of beauty, wellness, and postpartum services for women with a focus on utilizing TCM approaches in addressing women’s health issues. Our beauty, wellness, and postpartum services include but are not limited to womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, TCM-inspired prenatal massage, and Indonesian traditional abdominal binding. In addition, under the “Beauty Lab” brand, we also offer supplements products, including (i) TCM-inspired supplements products, such as Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets, designed to support uterine health, improve physical weakness, and balance endocrine functions for female customers; and (ii) beauty products, including ginseng soothing anti-allergy moisturizing wash, which provide comprehensive care for skin issues, and scalp health. Moreover, we also offer consultancy services to provide TCM-inspired therapy technical training and dietary therapy training to other well-established and reputable beauty salons, massage centers, and similar institutions. In March 2025, we launched a franchise model for our Beauty Lab brand, granting exclusive rights to independent third parties (the “Franchisees”) to operate branded beauty and wellness outlets. Franchisees are authorized to offer services such as scalp and hair care and women’s wellness services under the Beauty Lab brand. We derive franchise-related revenue mainly from initial franchise fees, royalty and promotional fees, brand management fees, training and administration fees. As of March 31, 2025 and as of the date of this prospectus, we had 1 and 3 franchisees, respectively. We generated revenue of $6,221,751 and $6,015,375, respectively, and achieved a net income of $1,199,085 and $821,743, respectively, for the years ended March 31, 2025 and 2024. We generated revenue primarily through the following: (i) beauty, wellness, and postpartum services; (ii) sales of products; (iii) consultancy services; and (iv) franchise activities. For the fiscal years ended March 31, 2025 and 2024, the revenue from beauty, wellness, and postpartum services amounted to $5,967,277 and $5,813,814, representing 96.0% and 96.6% of total revenue, respectively. The revenue from sales of products was $207,766 and $88,992 for the fiscal years ended March 31, 2025 and 2024, representing 3.2% and 1.5% of total revenue, respectively. The revenue from consultancy services was nil and $112,569 for the fiscal years ended March 31, 2025 and 2024, representing 0% and 1.9% of total revenue, respectively. The revenue from franchise activities was $46,708 and nil for the fiscal years ended March 31, 2025 and 2024, representing 0.8% and 0% of total revenue, respectively. Our principal executive office is located Hong Kong.

KindlyMD stock logo

KindlyMD NASDAQ:NAKA

$0.18 0.00 (-1.61%)
As of 05/8/2026 04:00 PM Eastern

Kindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.